Ray Ruby - Centre for Trials Research, Cardiff University

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 24 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Adaptive Clinical Trial of AZD7442 and SARS-CoV-2 Vaccination in Immunosuppressed Patients Highly Vulnerable to Infection with SARS-CoV-2 Virus (RAPID-PROTECTION): Protocol for a Multicentre, Interventional Open-Label, Randomised Controlled Trial

Melanie Varley,Joanne Euden,Richard Adams,Eleanor Barnes, Craig Bodman, Ernest Choy, Paola Cicconi, Vivien Dagley, Katie Ewer, Sian Griffin,Debbie Harris,Adrian Hill,Kerenza Hood, Steven Knapper, Shirley Pringle, Catherine Porter, Christian H. Ottensmeier,Lawrence Raisanen,Ruby Ray, Rebecca Tangney, Keith Wilson,Lisette Sheena Nixon,Emma Thomas-Jones, Mark Tuthill

BMJ OPENno. 1 (2025)

Cited0Views0WOSBibtex

Once Daily Cediranib and Weekly Paclitaxel to Prevent Malignant Bowel Obstruction in At-Risk Patients with Platinum-Resistant Ovarian Cancer (CEBOC): a Single-Arm, Phase II Safety Trial

Alexander D. Murphy,Catharine Porter,Ann White, Alys Irving,Richard Adams,Ruby Ray,Angela Casbard,Reem D. Mahmood, Suman Karanth,Cong Zhou,Julia Pugh,Chelsey Wheeler, Victoria Roberts, Giorgio Arnetoli,Zena Salih,Jurjees Hasan,Claire Mitchell,Robert D. Morgan,Andrew R. Clamp,Gordon C. Jayson

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCERno. 7 (2024): 1034-1040

Cited0Views0WOSBibtex

2022-RA-941-ESGO CEBOC, a Single-Arm Phase II Trial to Evaluate the Safety of Cediranib in the Prevention of Bowel Perforation in Platinum Resistant Ovarian Cancer

Alexander Murphy,Catharine Porter,Ann White, Alys Irving,Ruby Ray,Angela Casbard,Tracie-Ann Madden,Reem Mahmood, Robert Morgan,Julia Pugh,Chelsey Wheeler, Victoria Roberts, Giorgio Arnetoli,Zena Salih,Jurjees Hasan,Claire Mitchell,Andrew Clamp,Gordon Jayson

Ovarian cancer (2022)

Cited1Views0Bibtex

Use of Perioperative Prophylactic Antibiotics Following Excision of Ulcerated Skin Lesions in the UK: a National, Multispeciality Survey of Clinicians

Joshua Philip Totty,Rubeta N. Matin,Aaron Wernham,Ruby Ray,Emma Thomas-Jones,Rachel Angharad Abbott

Clinical and Experimental Dermatology（2021）

Cited0Views0WOSBibtex

A Prospective Phase II Study of Pre-Operative Chemotherapy then Short-Course Radiotherapy for High Risk Rectal Cancer: COPERNICUS

Simon Gollins,Nicholas West,David Sebag-Montefiore,Shabbir Susnerwala,Stephen Falk,Nick Brown,Mark Saunders,Philip Quirke,Ruby Ray,Philip Parsons,Gareth Griffiths,Tim Maughan,Richard Adams,Chris Hurt

British Journal of Cancer（2018）

Cited35Views0WOSNATUREBibtex

Long-term Results and Recurrence Patterns from SCALOP: a Phase II Randomised Trial of Gemcitabine- or Capecitabine-Based Chemoradiation for Locally Advanced Pancreatic Cancer

C N Hurt,S Falk,T Crosby,A McDonald,R Ray,G Joseph,J Staffurth,R A Abrams,G Griffiths,T Maughan,S Mukherjee

British Journal of Cancerno. 10 (2017): 1264-1270

Cited55Views0WOSNATUREBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn